British 7.7495933
ĠBi 9.123531
otech 3.242978
Ġpl 8.414039
c 0.0039677243
's 4.8641224
Ġcancer 8.362692
Ġdrug 1.2563425
ĠMar 7.7839937
im 4.9183397
ast 6.2603636
at 3.520215
ĠShows 11.873411
ĠPromise 1.9408754
, 2.7807348
ĠBut 2.3403337
ĠFaces 6.1791525
ĠH 5.2994485
urd 0.14190708
les 0.16848405
Ġto 3.5541327
ĠBecome 8.1345005
Ġa 1.0505593
ĠBlock 7.2274284
buster 0.011523551
Ċ 0.9221217
British 17.101686
ĠBi 0.19631884
otech 0.002704002
Ġpl 0.4720015
c 0.00035692935
Ġannounced 3.889236
Ġpromising 9.415701
Ġresults 0.32120493
Ġfor 2.7060723
Ġits 0.87364405
Ġcancer 1.7890692
Ġdrug 0.13186274
, 1.797649
ĠMar 0.18929851
im 0.0024935866
ast 0.009380348
at 0.00080475875
, 0.2594871
Ġwhich 2.8523817
Ġtargets 4.588557
Ġthe 1.4666919
Ġfast 6.9557695
- 0.13181011
growing 0.24950717
Ġmatrix 10.510396
Ġmet 0.92885023
all 0.033706702
op 0.03180036
rotein 0.051032934
ase 0.22954777
Ġ( 1.3130784
M 0.15656142
MP 0.010654163
) 0.37065578
Ġmarket 13.496115
. 0.68898106
ĠThe 1.5475731
Ġdrug 2.0619338
Ġis 1.7743707
Ġdesigned 4.0669866
Ġto 0.08042575
Ġinhibit 3.364239
Ġthe 0.9017246
Ġactivity 2.774975
Ġof 0.012744983
Ġspecific 6.6771507
ĠM 0.6763818
MP 0.0011622607
s 0.43607873
Ġthat 2.8732855
Ġpromote 3.3111873
Ġthe 1.9614458
Ġgrowth 0.42502856
Ġand 2.1269617
Ġspread 1.708795
Ġof 0.002194683
Ġcancer 0.4698899
Ġcells 0.8136301
. 0.48519933
ĠThe 1.7042952
Ġdrug 1.613125
Ġis 1.3564312
Ġcurrently 2.0934951
Ġin 1.0867947
ĠPhase 1.2478793
ĠIII 2.137984
Ġclinical 0.7176156
Ġtrials 0.2814788
, 1.922699
Ġand 1.2130123
Ġresults 5.070343
Ġfrom 1.3695595
Ġa 3.6074307
Ġrecent 3.425405
Ġtrial 3.269846
Ġdemonstrate 6.6402965
Ġthe 2.9632764
Ġdrug 1.4600679
's 0.8616691
Ġpotential 1.95716
Ġas 2.2980702
Ġa 0.20273557
Ġtherapeutic 3.866113
Ġoption 1.7264985
Ġfor 0.58163506
Ġcancer 2.5429108
Ġpatients 0.6605146
. 0.48239353
Ċ 0.8832235
Mar 5.0765023
im 0.0050253933
ast 0.0010622531
at 0.0004011717
Ġhas 2.5489426
Ġbeen 1.4838294
Ġproven 6.2218676
Ġto 0.66414344
Ġbe 1.4777404
Ġeffective 1.3472022
Ġagainst 1.846051
Ġa 2.0208566
Ġwide 2.5295463
Ġrange 0.594989
Ġof 0.0025262723
Ġcancers 1.4887929
, 0.63985056
Ġincluding 0.42087904
Ġpancreat 3.137096
ic 0.002275329
Ġcancer 1.6193824
, 0.343367
Ġcol 2.8353496
ore 0.0027799692
ct 0.0009361238
al 0.0031533078
Ġcancer 0.046943143
, 0.18183516
Ġand 1.8682632
Ġmetast 5.514706
atic 0.05225289
Ġmelan 1.0115834
oma 0.018697068
. 0.2572519
ĠThe 1.4484372
Ġdrug 0.64712954
Ġinhibits 6.1819606
Ġthe 0.95750606
Ġactivity 1.4554335
Ġof 0.008377819
ĠM 0.82050383
MP 0.0006912467
s 0.7219553
, 1.6674627
Ġwhich 1.0909725
Ġplay 3.2057078
Ġcritical 4.621249
Ġroles 0.017244563
Ġin 0.025541909
Ġmany 4.3257656
Ġphysiological 5.8245587
Ġprocesses 0.35874486
, 1.3958575
Ġsuch 1.5652428
Ġas 0.0025722838
Ġtissue 3.2840729
Ġremod 2.5509949
eling 0.057686888
, 0.7251759
Ġwound 3.9774387
Ġhealing 0.1463793
, 0.13437906
Ġand 0.80444163
Ġtumor 4.1373367
Ġinvasion 3.4717824
. 0.19562422
ĠWhen 6.046443
ĠM 3.5933292
MP 0.0008302919
s 0.25366354
Ġare 0.33314997
Ġover 3.208207
activated 3.5668733
, 0.20169523
Ġas 6.0607786
Ġin 1.833819
Ġcancer 0.68345386
, 0.48576486
Ġthey 1.2624295
Ġpromote 1.96241
Ġthe 0.98173124
Ġgrowth 0.29287267
Ġand 0.67533207
Ġspread 0.110075764
Ġof 0.0031656858
Ġcancer 0.6422457
Ġcells 0.11340139
Ġby 3.642212
Ġdegrading 4.9401946
Ġthe 2.016258
Ġext 2.4671063
race 0.0007460621
llular 3.5240468e-05
Ġmatrix 0.009176045
Ġ( 1.290493
EC 0.026122415
M 0.003955638
) 0.8019036
Ġsurrounding 2.372729
Ġthe 1.0296769
Ġtumor 1.8005216
. 0.41478333
Ċ 2.1201138
The 2.0586703
ĠPhase 3.9506123
ĠIII 0.22913417
Ġclinical 2.0024014
Ġtrial 0.16649151
Ġconducted 3.7221775
Ġby 0.65760565
ĠBritish 2.3028374
ĠBi 0.018796487
otech 0.0017176244
Ġpl 1.4549855
c 0.000599397
Ġdemonstrated 3.521922
Ġthat 0.5340453
ĠMar 0.7867837
im 0.00034047384
ast 0.000625162
at 0.00021145344
Ġcan 3.4740274
Ġsignificantly 3.0301065
Ġimprove 2.580412
Ġthe 0.98846847
Ġprogression 4.3529134
- 1.7617816
free 0.019717239
Ġsurvival 0.025382452
Ġrate 1.7766855
Ġof 0.5850559
Ġpatients 0.571643
Ġwith 0.3166249
Ġadvanced 1.3468364
Ġpancreat 3.124292
ic 0.000998529
Ġcancer 0.087426975
. 0.92140234
ĠIn 2.3564901
Ġthe 1.3292755
Ġtrial 1.1383977
, 0.06642078
Ġpatients 1.3826561
Ġwho 2.06002
Ġreceived 0.54499495
ĠMar 1.1790228
im 0.0004835843
ast 0.000448338
at 0.00027148862
Ġhad 1.3078854
Ġa 0.50538915
Ġmedian 2.352206
Ġprogression 2.9773734
- 0.14495836
free 0.0006046459
Ġsurvival 0.0021081863
Ġrate 1.7212266
Ġof 0.0760535
Ġ2 5.2760406
. 0.033451263
3 2.3426719
Ġmonths 0.6461913
, 1.298001
Ġcompared 0.6463986
Ġto 0.32076904
Ġ1 2.1184359
. 0.00820485
6 2.1402957
Ġmonths 0.07661589
Ġfor 1.1797248
Ġpatients 1.0777428
Ġwho 0.40231836
Ġreceived 0.75134385
Ġthe 2.8069024
Ġplacebo 1.5558267
. 0.26528955
ĠThe 1.6253254
Ġdrug 3.2612243
Ġshowed 3.9869819
Ġsimilar 2.7197912
Ġpromising 6.911974
Ġresults 0.13439794
Ġin 0.4662802
Ġthe 1.721799
Ġtreatment 3.0235443
Ġof 0.021338036
Ġother 3.648393
Ġcancers 2.4771245
Ġas 3.985683
Ġwell 0.01526597
. 0.7929576
Ċ 0.96660805
However 4.5034842
, 0.008568976
Ġdespite 3.8395503
ĠMar 3.4897695
im 0.00033653717
ast 0.00056200207
at 0.0002939055
's 0.19928823
Ġpotential 3.5411787
Ġto 1.4836875
Ġbecome 6.1126366
Ġa 0.19176508
Ġblockbuster 0.5704696
Ġdrug 0.62203556
, 0.37658152
Ġthere 2.3310578
Ġare 0.28114855
Ġsignificant 3.126633
Ġhurdles 1.6443145
Ġthat 1.8547957
ĠBritish 2.7669885
ĠBi 0.013635464
otech 0.0005377905
Ġpl 0.27817938
c 0.00035776378
Ġwill 1.769664
Ġhave 0.74703884
Ġto 0.0056003523
Ġovercome 0.13444962
. 3.258062
ĠFirstly 4.2986364
, 0.008032211
Ġthe 0.8620499
Ġdrug 0.5193624
's 2.147298
Ġpatent 4.550377
Ġprotection 2.0390794
Ġhas 3.3386364
Ġexpired 0.9885545
, 0.7499873
Ġwhich 2.2640371
Ġmeans 0.6327825
Ġthat 0.52048284
Ġthe 2.0486214
Ġdrug 1.136131
Ġis 1.7509428
Ġnow 2.57583
Ġavailable 1.774766
Ġas 4.335143
Ġa 0.50232214
Ġgeneric 0.6023596
Ġdrug 1.1601756
. 0.79534435
ĠThis 2.2412047
Ġwill 2.711396
Ġmake 2.9252691
Ġit 0.53348714
Ġdifficult 1.4426566
Ġfor 0.33752543
ĠBritish 1.5248654
ĠBi 0.011470613
otech 0.00029187708
Ġpl 0.13963944
c 0.0012490934
Ġto 0.03577769
Ġgenerate 4.696908
Ġsignificant 2.985852
Ġrevenue 1.1298648
Ġfrom 0.45237708
Ġthe 0.5793272
Ġdrug 0.3207139
. 0.8157697
Ċ 2.986639
Secondly 1.2680862
, 0.0023102195
Ġthe 0.9306424
Ġcompany 2.7452526
Ġwill 1.8249279
Ġneed 1.5141938
Ġto 0.04304771
Ġdemonstrate 4.358966
Ġthe 2.2062042
Ġdrug 0.94184613
's 0.13354746
Ġsafety 1.2321315
Ġand 0.6605554
Ġefficacy 0.24967225
Ġthrough 4.010752
Ġfurther 4.7516537
Ġclinical 1.032124
Ġtrials 0.20518798
. 0.8351138
ĠWhile 3.452138
Ġthe 1.0542855
Ġresults 3.8431904
Ġfrom 1.2982985
Ġthe 1.0913736
ĠPhase 0.43248647
ĠIII 0.1093544
Ġclinical 1.3849866
Ġtrial 0.08852797
Ġare 1.4532833
Ġpromising 0.7304525
, 0.07205017
Ġthey 3.2815962
Ġwill 1.8802421
Ġneed 1.9353802
Ġto 0.069651805
Ġbe 0.21422493
Ġreplicated 1.8655043
Ġin 0.5500126
Ġlarger 1.7266989
- 3.1573052
scale 0.010091406
Ġtrials 1.3184025
Ġto 1.2976265
Ġensure 2.0264716
Ġthat 0.6695052
Ġthe 0.4954454
Ġdrug 0.13752839
Ġis 0.8989312
Ġsafe 0.32500005
Ġand 0.25388074
Ġeffective 0.19727165
Ġfor 1.8863455
Ġa 3.434609
Ġwider 2.4873614
Ġrange 1.408676
Ġof 0.001278276
Ġpatients 0.7403225
. 0.113801636
Ċ 1.1153754
Third 3.0656893
ly 0.25483513
, 0.0072946534
ĠMar 2.927634
im 0.0002903283
ast 0.0007013879
at 0.00010593593
Ġfaces 4.823377
Ġcompetition 4.7038803
Ġfrom 0.11696444
Ġother 1.7904544
ĠM 3.4343042
MP 0.0011425115
Ġinhibitors 0.13850859
Ġcurrently 3.3139129
Ġin 1.0987895
Ġdevelopment 1.2179722
. 0.7552152
ĠSeveral 4.508337
Ġother 2.2654696
Ġpharmaceutical 5.3193016
Ġcompanies 0.11970458
Ġare 0.9803677
Ġdeveloping 1.3196442
ĠM 0.96753407
MP 0.0010134461
Ġinhibitors 0.08463508
Ġto 2.1395733
Ġtarget 2.1225996
Ġcancer 2.4152598
, 1.8361825
Ġsuch 2.501218
Ġas 0.0025924847
ĠGl 5.290847
ax 0.8202117
o 0.03492184
Smith 0.060665984
K 0.015408628
line 0.011363535
Ġpl 3.0123227
c 0.00014492373
's 0.09950462
ĠB 5.6207457
MS 1.3174173
- 1.1466588
275 6.8745904
291 8.935463
Ġand 0.90528375
ĠMillennium 8.931404
ĠPharmaceutical 0.59417635
s 0.11333843
ĠInc 3.9294631
.' 1.2848288
s 0.00047064314
Ġ( 4.4191413
now 5.0290008
ĠT 5.4956937
aked 0.050491937
a 0.008070306
ĠPharmaceutical 0.6528868
ĠCo 1.2802663
. 1.5696416
ĠLtd 0.21202973
.) 0.28599378
ĠPrin 12.217422
om 6.651644
ast 1.7598199
at 0.06588655
. 0.40293407
ĠThis 4.8280425
Ġmeans 3.199881
Ġthat 0.048172303
ĠBritish 1.6202407
ĠBi 0.0049606375
otech 0.00075417483
Ġpl 0.057841603
c 0.019575909
Ġwill 0.42936835
Ġneed 1.1295012
Ġto 0.011415929
Ġwork 3.1372166
Ġhard 1.6793016
Ġto 0.058583993
Ġdifferentiate 4.428954
ĠMar 2.9084985
im 0.00023738743
ast 0.0004589541
at 8.8410365e-05
Ġfrom 0.3865164
Ġits 2.0600688
Ġcompetitors 0.26614025
Ġand 2.956267
Ġposition 5.9290414
Ġit 1.6810225
Ġas 0.47890192
Ġthe 1.8412735
Ġmost 3.159957
Ġeffective 1.4227426
ĠM 0.7092273
MP 0.00033737256
Ġinhibitor 0.02405759
. 1.8883314
Ċ 0.77533287
British 4.416967
ĠBi 0.009327462
otech 0.000541011
Ġpl 0.06070987
c 0.0002961714
Ġwill 2.3913023
Ġneed 2.9154334
Ġto 0.02903297
Ġinvest 4.535291
Ġin 1.3716718
Ġmarketing 3.6222446
Ġand 1.337624
Ġresearch 2.4952211
Ġand 2.0819128
Ġdevelopment 0.06410607
Ġto 0.9706202
Ġensure 1.3875855
Ġthat 0.1474775
ĠMar 1.1133479
im 8.912656e-05
ast 0.00043056931
at 7.613187e-05
Ġbecomes 2.448983
Ġa 0.3364165
Ġblockbuster 0.42688158
Ġdrug 0.20290911
. 0.67868954
ĠThe 1.7204745
Ġcompany 0.3045016
Ġwill 1.158197
Ġneed 1.2674859
Ġto 0.02216179
Ġconduct 5.285756
Ġfurther 2.9760303
Ġtrials 2.1371152
Ġto 0.71053576
Ġdemonstrate 3.0123162
Ġthe 0.97159344
Ġdrug 0.30319983
's 0.018943781
Ġsafety 0.5607594
Ġand 0.067837805
Ġefficacy 0.15586105
Ġand 2.2466815
Ġto 1.7347293
Ġdetermine 3.1380827
Ġthe 1.2682747
Ġoptimal 2.2093832
Ġdose 1.6976377
Ġand 1.5990237
Ġtreatment 4.811532
Ġfor 3.4272454
Ġeach 1.2017639
Ġcancer 3.8131466
Ġtype 2.215481
. 0.24000764
ĠAdditionally 3.964518
, 0.0040594093
Ġthe 0.8844149
Ġcompany 0.43370315
Ġwill 0.18781374
Ġneed 0.36683193
Ġto 0.0061620823
Ġdevelop 2.2230718
Ġstrong 6.4290967
Ġpartnerships 1.3575153
Ġwith 0.21655989
Ġphysicians 5.178117
, 1.7187636
Ġhospitals 1.572248
, 0.14314449
Ġand 0.5577337
Ġother 1.7180731
Ġstakeholders 5.249675
Ġto 0.83309966
Ġensure 0.8522486
Ġthat 0.15188128
ĠMar 2.0039427
im 0.00013204545
ast 0.00044285253
at 0.00012203379
Ġis 0.8304935
Ġwidely 3.9708736
Ġprescribed 4.525631
Ġand 0.8920744
Ġused 1.7913126
Ġin 1.5142796
Ġthe 1.2921195
Ġtreatment 1.7353034
Ġof 0.028957807
Ġcancer 0.50927156
. 0.4779861
Ċ 0.9039678
Despite 3.623042
Ġthe 1.0879825
Ġchallenges 1.1422297
, 1.4756542
ĠMar 1.9946721
im 0.00030344594
ast 0.0008805229
at 0.00012810968
's 2.0744913
Ġpotential 1.7926083
Ġto 2.2485237
Ġbecome 0.2798568
Ġa 0.061895404
Ġblockbuster 0.098792344
Ġdrug 0.0727751
Ġis 0.8989355
Ġsignificant 3.8285222
. 0.5618875
ĠThe 1.2643251
Ġdrug 0.6813556
Ġhas 1.6434941
Ġdemonstrated 3.069412
Ġpromising 1.3269391
Ġresults 0.19408996
Ġin 0.65599304
ĠPhase 2.6258402
ĠIII 0.07287376
Ġclinical 0.39822873
Ġtrials 0.05364255
Ġand 1.4254574
Ġhas 2.111957
Ġthe 2.1419659
Ġpotential 0.103753865
Ġto 0.035017025
Ġbecome 1.195929
Ġa 0.22515318
Ġvaluable 3.8920028
Ġtherapeutic 2.643033
Ġoption 0.0953964
Ġfor 0.25631195
Ġcancer 0.8088581
Ġpatients 0.039754085
. 0.20296489
ĠBritish 2.3430645
ĠBi 0.0059868568
otech 0.00085385767
Ġpl 0.008709479
c 0.013461882
Ġmust 5.8173995
Ġwork 2.2672677
Ġhard 0.7018126
Ġto 0.079844296
Ġovercome 4.2057147
Ġthe 1.0944945
Ġhurdles 1.7521005
Ġand 1.5167519
Ġposition 5.1389823
ĠMar 0.8191821
im 0.00014134373
ast 0.00043700845
at 8.852958e-05
Ġas 0.10138027
Ġthe 0.8838832
Ġmost 0.63589394
Ġeffective 0.05451841
ĠM 0.09945577
MP 0.00042949457
Ġinhibitor 0.004783587
Ġon 3.9556718
Ġthe 0.0075565255
Ġmarket 0.027908504
. 0.25041458
ĠWith 6.098046
Ġthe 1.1310518
Ġright 3.8586872
Ġinvestment 3.6586294
Ġand 0.8538678
Ġstrategy 2.4563963
, 0.054147422
ĠMar 1.7542284
im 0.00010355082
ast 0.000540414
at 8.7696986e-05
Ġcould 0.6306436
Ġbecome 0.5315663
Ġa 0.32416564
Ġkey 5.86583
Ġplayer 1.1515945
Ġin 0.04987755
Ġthe 0.07960926
Ġfight 5.2394457
Ġagainst 0.030049665
Ġcancer 0.12476709
. 0.26246798
